약국 자동화 시장 : 제품별, 최종 사용자별, 시설별 - 세계 예측(-2030년)

The global pharmacy automation market is experiencing significant growth in 2024, driven by the increasing incidence of medication errors and the growing need for enhanced patient safety. The market is projected to reach USD 6.65 billion in 2024 from USD 10.00 billion in 2030, expanding at a CAGR of 7.1% from 2024 to 2030. According to the World Health Organization (WHO), nearly 50% of all medication errors occur during the prescription or ordering process. Additionally, studies indicate that nurses and pharmacists identify between 30% and 70% of medication-ordering errors. Hospitals and pharmacies are increasingly adopting advanced pharmacy automation solutions to mitigate these risks to enhance accuracy, efficiency, and workflow management. This rising demand for automation is expected to accelerate market growth in the coming years.

Based on type, the robots/robotic automated medication dispensing subsegment accounted for the largest share in automated medication dispensing and storage segment in 2023"

Based on type, the market for automated medication storage and dispensing systems is categorized into robots/robotic automated dispensing systems, carousels, automated dispensing cabinets (ADCs), and others. Robot/robotic automated dispensing systems accounted for the largest share in 2023 of this market. These systems assist in reducing the rate of errors by widening the administration accuracy rate by integrating robots with single/multiple robotic arms that are capable of performing the filling, storing, and dispensing of medications, thereby reducing the chances of manual errors.

"North America dominated the pharmacy automation market in 2023."

The pharmacy automation market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the pharmacy automation market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing cases of the chronic diseases, rising demand for assisted living and long term care centers and high prescription volume resulting in increased demand of automation in North America market.

Companies such as BD, OMNICELL, McKesson, and Baxter are leading the market by investing in smart, connected pharmacy automation solutions. For instance, in June 2022, BD invested USD 1.525 billion in acquisition of Parata Systems, expanding BD's footprint in robotic medication dispensing and AI-based workflow automation. This acquisition is expected to accelerate pharmacy automation adoption, particularly in hospitals and centralized prescription fulfillment centers.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation - Directors: 35%, Managers: 40%, and Others: 25%
• By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Oracle (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Mckesson Corporation (US) are some of the key players in the pharmacy automation market.

The study includes an in-depth competitive analysis of these key players in the pharmacy automation market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the pharmacy automation market by product type (automated medication dispensing and storage systems, automated packaging and labeling systems, automated tabletop counters, automated medication compounding systems, pharmacy management software (PMS/PIMS/PIS), and other pharmacy automation systems (pharmacy kiosks, pneumatic tubes, tablet splitters, and others), by component (hardware, software, and service), by application (centralized operations and decentralized operations), by facility type (large-scale pharmacies and small and mid-size pharmacies), and by end-user (hospital pharmacies, ambulatory surgery center (ASC), ambulatory care center (ACC), and other outpatient settings, long-term care facilities & assisted living facilities, retail pharmacies, and pharmacy benefit management organization and mail-order pharmacies) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmacy automation market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the pharmacy automation market. Competitive analysis of upcoming startups in the pharmacy automation market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the pharmacy automation market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (growing need to minimize medication error, decentralization of pharmacies, rising geriatric population leading to increased adoption of automated dispensing systems, growing focus on automation to reduce labor costs, increasing specialty drug dispensing), restraints (high initial capital investments, reluctance to adopt pharmacy automation systems, limited suitability for all medication types, and lack of skilled personnel), opportunities (rising online sales of medicines, expansion of telepharmacy and remote patient management, rising healthcare costs expected to drive the market growth),and challenges (stringent regulatory procedures, risk of cross-contamination, technical failures and system reliability issues, risk of drug name selection errors).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmacy automation market
• Market Development: Comprehensive information about lucrative markets - the report analyses the pharmacy automation market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmacy automation market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Oracle (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Mckesson Corporation (US), among others in the pharmacy automation market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 LIMITATIONS
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET ESTIMATION METHODOLOGY
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 OVERALL STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PHARMACY AUTOMATION MARKET OVERVIEW
• 4.2 PHARMACY AUTOMATION MARKET, BY END USER AND COUNTRY
• 4.3 PHARMACY AUTOMATION MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 PHARMACY AUTOMATION MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing need to minimize medication errors
    • 5.2.1.2 Decentralization of pharmacies
    • 5.2.1.3 Rising geriatric population and subsequent uptake of automated dispensing systems
    • 5.2.1.4 Growing focus on automation to reduce labor costs
    • 5.2.1.5 Increasing demand for specialty drug dispensing
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High initial capital investments
    • 5.2.2.2 Reluctance to adopt pharmacy automation systems
    • 5.2.2.3 Shortage of skilled personnel
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Gradual shift to online pharmacy services
    • 5.2.3.2 Expansion of telepharmacy & remote patient management services
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulatory process for automated pharmacy systems
    • 5.2.4.2 Risk of cross-contamination
    • 5.2.4.3 Technical failures and system reliability issues
    • 5.2.4.4 Medication dispensing risks associated with drug name selections
• 5.3 INDUSTRY TRENDS
  • 5.3.1 COMPACT SOFTWARE CONFIGURATIONS WITH MINIMAL PHYSICAL FOOTPRINTS
  • 5.3.2 PHARMACY ROBOTICS FOR PRESCRIPTION DISPENSING
  • 5.3.3 RFID TECHNOLOGY FOR ADVANCED MEDICATION TRACKING
  • 5.3.4 CLOUD-BASED PHARMACY AUTOMATION MANAGEMENT SOLUTIONS
  • 5.3.5 INTEGRATION WITH EHR FOR ENHANCED INTEROPERABILITY
  • 5.3.6 ROLE OF BIG DATA IN HEALTHCARE AUTOMATION
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Robotics
    • 5.7.1.2 Robotic Process Automation (RPA)
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 E-prescribing systems
    • 5.7.2.2 EHR integration
    • 5.7.2.3 Barcoding & scanning technology
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 AI & ML
    • 5.7.3.2 Telepharmacy
    • 5.7.3.3 Cold chain management solutions
• 5.8 TARIFF & REGULATORY ANALYSIS
  • 5.8.1 TARIFF DATA (HS CODE 9032)
  • 5.8.2 TARIFF DATA (HS CODE 8422)
  • 5.8.3 TARIFF DATA (HS CODE 8479)
  • 5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.5 REGULATORY ANALYSIS
    • 5.8.5.1 North America
    • 5.8.5.2 Europe
    • 5.8.5.3 Asia Pacific
    • 5.8.5.4 Middle East & Africa
    • 5.8.5.5 Latin America
• 5.9 TRADE ANALYSIS
  • 5.9.1 TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 9032)
  • 5.9.2 TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 8422)
  • 5.9.3 TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 8479)
• 5.10 PRICING ANALYSIS
  • 5.10.1 INDICATIVE PRICE OF PHARMACY AUTOMATION, BY PRODUCT (2023)
  • 5.10.2 INDICATIVE PRICE OF PHARMACY AUTOMATION DEVICES, BY REGION (2023)
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11.2 BARGAINING POWER OF BUYERS
  • 5.11.3 THREAT OF SUBSTITUTES
  • 5.11.4 THREAT OF NEW ENTRANTS
  • 5.11.5 BARGAINING POWER OF SUPPLIERS
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS FOR PHARMACY AUTOMATION
  • 5.12.2 JURISDICTION & TOP APPLICANT COUNTRIES FOR PHARMACY AUTOMATION
  • 5.12.3 LEADING PATENTS IN PHARMACY AUTOMATION MARKET
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 END-USER ANALYSIS
  • 5.14.1 UNMET NEEDS
  • 5.14.2 END-USER EXPECTATIONS
• 5.15 KEY CONFERENCES & EVENTS, 2024-2025
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 CASE STUDY 1: KING SALMAN MILITARY HOSPITAL IMPLEMENTS PHARMACY AUTOMATION
  • 5.16.2 CASE STUDY 2: EVERSPRING PHARMACY AIMED TO IMPROVE EFFICIENCY IN MEDICATION DISPENSING & PACKING WITH LOW COSTS
  • 5.16.3 CASE STUDY 3: MCKESSON IMPLEMENTED CLINICAL PROGRAM SOLUTIONS FOR REAL-TIME PATIENT ADHERENCE
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 BUSINESS MODELS
  • 5.18.1 DIRECT SALES MODEL (CAPITAL PURCHASE MODEL)
  • 5.18.2 SUBSCRIPTION-BASED MODEL (SOFTWARE-AS-A-SERVICE: SAAS)
  • 5.18.3 PAY-PER-USE MODEL (TRANSACTION-BASED PRICING)
  • 5.18.4 LEASE/RENTAL MODEL
  • 5.18.5 MANAGED SERVICES MODEL (OUTSOURCING & FULL-SERVICE CONTRACTS)
  • 5.18.6 FREEMIUM MODEL WITH PREMIUM UPGRADES
• 5.19 IMPACT OF AI/GENERATIVE AI ON PHARMACY AUTOMATION MARKET
  • 5.19.1 KEY USE CASES
  • 5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    • 5.19.2.1 CASE STUDY 1: GIANT EAGLE LEVERAGES AI-DRIVEN AUTOMATION TO ENHANCE PHARMACY EFFICIENCY & PATIENT SAFETY
  • 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.19.3.1 Medication management market
    • 5.19.3.2 Medical robots market
    • 5.19.3.3 Digital pharmacy market
  • 5.19.4 USER READINESS & IMPACT ASSESSMENT
    • 5.19.4.1 User readiness
      • 5.19.4.1.1 User A: Hospital pharmacies
      • 5.19.4.1.2 User B: Retail pharmacies
    • 5.19.4.2 Impact assessment
      • 5.19.4.2.1 User A: Hospital pharmacies
      • 5.19.4.2.2 User B: Retail pharmacies

6 PHARMACY AUTOMATION MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS
  • 6.2.1 ROBOTIC AUTOMATED DISPENSING SYSTEMS (ROBOTS)
    • 6.2.1.1 High adoption of robots to reduce dispensing errors in hospitals to drive market
  • 6.2.2 CAROUSELS
    • 6.2.2.1 Improved inventory control & workflow to fuel uptake
  • 6.2.3 AUTOMATED DISPENSING CABINETS (ADCS)
    • 6.2.3.1 Provision of secured medication storage & drug tracking benefits to support market growth
• 6.3 AUTOMATED PACKAGING & LABELING SYSTEMS
  • 6.3.1 VIAL PACKAGING
    • 6.3.1.1 Increasing demand for high-quality glass & sustainable vial packaging to drive market
  • 6.3.2 POUCH PACKAGING
    • 6.3.2.1 Efficient design for unit/multi-dose medication dispensing to fuel uptake
  • 6.3.3 BLISTER PACKAGING
    • 6.3.3.1 Rising emphasis on sustainability & smart packaging to drive market
• 6.4 AUTOMATED TABLETOP COUNTERS
  • 6.4.1 GROWING FOCUS ON INCREASING OPERATING SPEED TO BOOST DEMAND
• 6.5 AUTOMATED MEDICATION COMPOUNDING SYSTEMS
  • 6.5.1 MINIMIZATION OF COMPOUNDING ERRORS AND ELIMINATION OF MEDICATION OUTSOURCING EXPENSES TO FUEL MARKET
• 6.6 PHARMACY MANAGEMENT SOFTWARE (PMS/PIMS/PIS)
  • 6.6.1 INTEGRATION OF AI FOR REGULATORY ADHERENCE TO PROPEL MARKET
• 6.7 OTHER PHARMACY AUTOMATION SYSTEMS

7 PHARMACY AUTOMATION MARKET, BY COMPONENT

• 7.1 INTRODUCTION
• 7.2 HARDWARE
  • 7.2.1 ABILITY TO PROVIDE RAPID EFFICIENCY WITH LOW RISK OF MANUAL MEDICATION ERRORS TO DRIVE MARKET
• 7.3 SOFTWARE
  • 7.3.1 ON-PREMISE DEPLOYMENT MODELS
    • 7.3.1.1 Provision of secure, customized, and regulatory-compliant solutions for sensitive patient data to fuel uptake
  • 7.3.2 CLOUD-BASED DEPLOYMENT MODELS
    • 7.3.2.1 Growing focus on scalability, AI-integration, and remote accessibility to drive market
• 7.4 SERVICES
  • 7.4.1 OPTIMIZATION OF PHARMACY OPERATIONS THROUGH COMPREHENSIVE AUTOMATION SERVICES TO SUPPORT MARKET GROWTH

8 PHARMACY AUTOMATION MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 CENTRALIZED OPERATIONS
  • 8.2.1 HIGHLY BENEFICIAL FOR LARGE HEALTHCARE FACILITIES FOR HIGH-VOLUME MEDICATION PROCESSING TO FUEL MARKET
• 8.3 DECENTRALIZED OPERATIONS
  • 8.3.1 UTILIZATION OF ADCS IN EMERGENCY DEPARTMENTS FOR REAL-TIME MEDICATION ADMINISTRATION TO PROPEL MARKET

9 PHARMACY AUTOMATION MARKET, BY FACILITY TYPE

• 9.1 INTRODUCTION
• 9.2 LARGE-SCALE PHARMACIES
  • 9.2.1 INTEGRATION OF AI & ML INTO COMPLEX WORKFLOWS TO FUEL UPTAKE
• 9.3 SMALL & MID-SIZED PHARMACIES
  • 9.3.1 GROWING FOCUS ON OFFERING AFFORDABLE AUTOMATED SOLUTIONS TO PROPEL MARKET

10 PHARMACY AUTOMATION MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITAL PHARMACIES
  • 10.2.1 INPATIENT PHARMACIES
    • 10.2.1.1 Growing need to minimize waiting times and reduce medication errors to drive market
  • 10.2.2 OUTPATIENT PHARMACIES
    • 10.2.2.1 Growing focus on enhancing patient convenience and complying with medication adherence to fuel market
• 10.3 AMBULATORY SURGERY CENTERS (ASCS), AMBULATORY CARE CENTERS (ACCS), AND OTHER OUTPATIENT SETTINGS
  • 10.3.1 INTEGRATION OF ROBOTICS AND AI INTO AUTOMATED SOLUTIONS TO DRIVE MARKET
• 10.4 LONG-TERM CARE AND ASSISTED LIVING FACILITIES
  • 10.4.1 EXPANSION IN GERIATRIC POPULATION TO FUEL MARKET
• 10.5 RETAIL PHARMACIES
  • 10.5.1 GROWING REQUIREMENT FOR AUTOMATED TECHNOLOGY TO ASSIST WITH RAPID MEDICATION DISPENSING TO PROPEL MARKET
• 10.6 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES
  • 10.6.1 RISING FOCUS ON AUTOMATED DISPENSING FACILITIES FOR 90-DAY MEDICATION SUPPLIES TO SUPPORT MARKET GROWTH

11 PHARMACY AUTOMATION MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Technological shift towards advanced pharmacy solutions to drive market
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing uptake of AI & ML to fuel market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 UK
    • 11.3.2.1 Growing cases of medication errors to fuel uptake
  • 11.3.3 GERMANY
    • 11.3.3.1 Hub for advanced automation technologies to propel market
  • 11.3.4 FRANCE
    • 11.3.4.1 Favorable government initiatives for healthcare digitization to drive market
  • 11.3.5 ITALY
    • 11.3.5.1 Rising focus on enhancing healthcare efficiency to support market growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Rising uptake of ADCs for high prescription volumes to fuel uptake
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Incorporation of robotic dispensing systems in pharmacies to fuel market
  • 11.4.3 CHINA
    • 11.4.3.1 Rising need for medication safety to support market growth
  • 11.4.4 INDIA
    • 11.4.4.1 Favorable digital health initiatives to propel market
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 High incidence of prescription errors to drive market
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing focus on medication safety to fuel uptake
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Rising adoption of automation solutions to drive market
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACY AUTOMATION MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Component footprint
    • 12.5.5.5 Application footprint
    • 12.5.5.6 Facility type footprint
    • 12.5.5.7 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of key emerging players/startups
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/SOFTWARE COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT/SERVICE LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 BD
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
      • 13.1.1.3.2 Other developments
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 OMNICELL
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product/Service launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 KUKA AG (SWISSLOG HEALTHCARE)
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product/Service launches
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Other developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 BAXTER
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Products/Service launches
      • 13.1.4.3.2 Other developments
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 MCKESSON CORPORATION
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product/Service launches
      • 13.1.5.3.2 Other developments
  • 13.1.6 ORACLE
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product/Service launches & enhancements
      • 13.1.6.3.2 Deals
    • 13.1.6.4 MnM view
      • 13.1.6.4.1 Key strengths
      • 13.1.6.4.2 Strategic choices
      • 13.1.6.4.3 Weaknesses & competitive threats
  • 13.1.7 CAPSA HEALTHCARE
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product/Service launches & enhancements
      • 13.1.7.3.2 Deals
      • 13.1.7.3.3 Expansions
      • 13.1.7.3.4 Other developments
  • 13.1.8 YUYAMA CO., LTD.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product/Service launches
  • 13.1.9 ARXIUM
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Services offered
  • 13.1.10 SCRIPTPRO, LLC
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Services offered
  • 13.1.11 RXSAFE, LLC
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 PEARSON MEDICAL TECHNOLOGIES, LLC
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Services offered
    • 13.1.12.3 Recent development
      • 13.1.12.3.1 Products/Service launches
      • 13.1.12.3.2 Other developments
  • 13.1.13 DEENOVA S.R.L.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Services offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product/Service launches
      • 13.1.13.3.2 Deals
      • 13.1.13.3.3 Expansions
      • 13.1.13.3.4 Other developments
  • 13.1.14 MEDICAL PACKAGING INC., LLC
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Services offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Product/Service launches
  • 13.1.15 TENSION PACKAGING & AUTOMATION
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Services offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product/Service launches
      • 13.1.15.3.2 Deals
      • 13.1.15.3.3 Other developments
  • 13.1.16 NORITSU PHARMACY AUTOMATION
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Services offered
      • 13.1.16.2.1 Product/Service launches
  • 13.1.17 EUCLID MEDICAL PRODUCTS
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products/Services offered
    • 13.1.17.3 Recent developments
      • 13.1.17.3.1 Deals
  • 13.1.18 TOUCHPOINT MEDICAL SOLUTIONS
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products/Services offered
    • 13.1.18.3 Recent developments
      • 13.1.18.3.1 Product/Service launches
      • 13.1.18.3.2 Deals
  • 13.1.19 INNOVATION ASSOCIATES (IA)
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products/Services offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product/Service launches
      • 13.1.19.3.2 Deals
      • 13.1.19.3.3 Expansions
      • 13.1.19.3.4 Other developments
  • 13.1.20 JFCRX
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products/Services offered
    • 13.1.20.3 Recent developments
      • 13.1.20.3.1 Product/Service launches
      • 13.1.20.3.2 Deals
      • 13.1.20.3.3 Expansions
• 13.2 OTHER PLAYERS
  • 13.2.1 WILLACH GROUP
  • 13.2.2 PHARMACY AUTOMATION SYSTEMS, LLC
  • 13.2.3 ASTERES INC.
  • 13.2.4 NEWLCON
  • 13.2.5 ACCU-CHART PLUS HEALTH CARE SYSTEMS, INC.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS